InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Anderson Robert A.. Director active across 1 company, notably bioAffinity Technologies, Inc.. Aggregated, 6 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Activity tracked since 1 January 2023. The latest transaction was filed on 1 July 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Anderson Robert A. is a declarant and Director of bioAffinity Technologies, Inc. (XNAS). He has 6 filings in total, and the 6 sampled filings run from 2022-12-02 to 2024-07-02; the modal transaction nature is Attribution.